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o-enantiomer-containing species were essentially inactive. However, we remained concerned about the remote possibility thatfluorinesubstitutionmight alterenantiomeric specificity in our test systems. To address this concern, we enzymatically prepared D-e,t-FMTX and studied its activity. We included D-MTX in these studies to expand the data base on this contaminant found in clinical MTX preparations and 4-amino-lo-methylpteroyl-D,L-(4-methylene-Glu) [7] were gifts of Dr. M. G. Nair (University of South Alabama, Mobile). Other chemicals were reagent grade or higher.
PI.

Materials and Methods
L-MTX was a gift of Lederle (Pearl River
D-e.t-FMTX was prepared by exhaustive digestion of D,L-e,t-FMTX (31 with carboxypeptidase G2 (CPG2). which CPG2, carboxypeptidase G,: DHFR, dihydrofolate reductase; and dTMP. thymidylate. specifically releases L-amino acids from pteroates (vide infra). D,L-e,t-FMTX (20 pmol) was hydrolyzed (37") by 40 I.U. of CPG2 in 25 mM pH 7.3 and 0.1 mM ZnCl, (200mL) . After no further absorbance change at 320nmwasobserved (t = 15 min), incubation wascontinued for 30 min. Based on AA,,, and the E320,pH7 3 for production of 4-amino-lo-methylpteroate
[8], 49% of the substrate was hydrolyzed. The resulting solution was chromatographed in two portions on DE-52 (0.7 x 21 cm; Whatman, Clifton, NJ) equilibrated at 4" with 50mM NH4HC0s, pH 8.0. After loading and washing with 70 mL of initial buffer, each column was eluted with a linear gradient (500 mL total) from 50 to 200mM NH.,HCOs, pH 8.0. 4-Amino-IO-methylpteroate, identified by its UV spectrum at pH 13 and HPLC retention time [9] ,-was well resolved from De.t-FMTX. Fractions containine material with a UV spectrum and HPLC retention"time similar to D,L-e,t-FMTX were lyophilized. Exhaustive CPG2 digestion of this material showed it contained <4% of the L-isomer (D-e,t-FMTX does not inhibit CPG,; vide infra). [4] . Cell outgrowth inhibition and drug concentration inhibiting cell growth by 50% (E&) were determined as described [6] . CCRF-CEM cells used as a DHFR source and to determine ~csr, were Mycoplasma free (Gen-Probe Inc., San Diego, CA). Studies on thymidylate (dTMP) biosynthesis and inhibition of [3H]MTX uptake were completed within 11 days and 2 months, respectively, of this negative test; testing 10 months later showed contamination in all lines. o-e,t-FMTX was depleted prior to this discovery so the studies could not be repeated. However, since cells grew normally during the studies 
Results and Discussion
CPG2 specificity . CPG, is believed to be similar to CPG , which specifically hydrolyzes C-terminal L-Glu, ~-Asp, and L-Gln from oligopeptides, N-acylated amino acids, folates, and folate analogs [2, 8] . Stereospecificity of CPGz was verified by showing that, at 100 PM, D-MTX was hydrolyzed at ~0.2% the rate of L-MTX; the low rate measured may result from L-MTX contamination since limit digestion of D-MTX indicated the presence of ~2% L-MTX. Also, over 10-50 PM L-MTX, the hydrolysis rate was the same for L-MTX or D,L-MTX and the E3z0 for the reaction with D,L-MTX was -50% that with L-MTX (3900 vs 766Ocm-' M-l). Quantitation of 20yM L-MTX based on CPGrcatalyzed hydrolysis was unaffected by the presence of 100 PM D-MTX or 40 PM D-e,t-FMTX. Thus, similar to CPG, [S] , CPGz was specific for L-Glu and D-Glu did not inhibit its action [2] .
, and 4-amino-lo-methylpteroyl-D,L-(4-methylene-Glu) were hydrolyzed 100, 50, and 0%, respectively, by CPG2. These data (not shown) suggested that some Glu analogs could be released in an apparently L-enantiomerspecific manner, but demonstrated sensitivity of CPGz towards y-substituents. Thus if D,L-e,t-FMTX were a substrate, only the L-enantiomer might be hydrolyzed. [17] were lowest for the D-enantiomers (Table l) , further indicating weaker interaction with DHFR. Previous work also showed that D-MTX was weaker than L-MTX as an inhibitor of human and murine DHFR based on lcso values [2] . Slopes of inhibition curves were not reported in that study.
[3H]MTX uptake inhibition. MTX and FMTX isomers share transport systems in H35 hepatoma [3] and CCRF-CEM cells [4] . Preliminary studies showed that 4 PM D,L-MTX was equivalent to 2 PM L-MTX in decreasing the initial velocity ( ui) of transport and accumulation at 30 min of 1 PM L-['H]MTX. D-MTX at GlO PM had no effect on u, and caused only a slight decrease in accumulation at 30min (not shown); 20pM D-MTX affected both vi and accumulation at 30 min, but the effect was less than that of 4 VM D,L-MTX (Fig. 1) . Effects of D-MTX on MTX transport were not examined previously [2] . D.L-e.r-FMTX at 8 PM inhibited L-[3H]MTX uptake; 40 PM o-e,r-FMTX was required to achieve the same level of inhibition (Fig.  1) . Thus, D-MTX and D-e.t-FMTX were much weaker than the corresponding L-enantiomers as inhibitors of L-['HI-MTX uptake. Assuming that inhibitory potency reflects affinity for the carrier and that other routes of transport are not used at higher efficiency, these data suggest that D-enantiomers are poorly transported. Uptake measurements. An attempt was made to use CPG, hydrolysis to assess the enantiomeric composition of intracellular radiolabel following exposure of CCRF-CEM cells to L-
were hydrolyzed by CPG2 to yield 296% and 45% [3H]4-amino-10-methylpteroate. respectively, indicating that the approach was feasible. The extensive sample processing required in cell studies, however, resulted in significant conversion of radiolabel to unidentifiable products even in control samples; thus intracellular drug could not be studied.
Inhibition ofd734P biosynthesis. dTMP biosynthesis was measured by conversion of [5--'H]dUrd to dTMP in intact cells. Inhibition by L-MTX was concentration-dependent and 2 ,uM D,L-MTX was equivalent to 1 PM L-MTX ( Fig.  2A) . D-MTX at 10~M inhibited dTMP biosynthesis, but was less potent than 0.5 PM L-MTX; 2 yM D-MTX was no different from control (not shown). Inhibition of dTMP biosynthesis by D-MTX was not studied previously [2] . D,Le,r-FMTX at 2~uM took longer to initiate inhibition of dTMP biosynthesis than did 0.5 yM L-MTX (Fig. 2B) . De,t-FMTX at 2.8 uM was not different from control: 10 uM n-e,r-FMTX eventually caused inhibition but took much longer than 2 PM D,t,-e,t-FMTX. Thus, D-MTX and D-e+ FMTX were weaker inhibitors of dTMP biosynthesis than were the corresponding L-enantiomers.
Ourgrowrh inhibition. Using a 120-hr exposure period, L-MTX was about 2-and 33-fold more effective than D,L-MTX and D-MTX, respectively, as an inhibitor of CCRF-CEM cell growth (Table 1) . These results are similar to earlier studies on L1210 cells using unpurified D-MTX, but dissimilar to earlier results with CCRF-CEM cells where the EC,, for purified D-MTX was >lOOO nM [2] . It is doubtful that trace contamination of our D-MTX by L-MTX (~2%. above) accounts for the difference in potency found in the two studies. A likely source for the difference is the conditions used to assess growth inhibition. Earlier studies used initial densities of 5 x 10" cells/ml and allowed 3 generations of growth [2] , while our initial density was 1 X lo4 cells/ml and allowed 5-6 generations. Slower uptake of D-MTX and weaker inhibition of DHFR may mean that a longer exposure time is required for the effects to be evident (cf. Fig. 2 ). D-e.t-FMTX was also a much less potent inhibitor than D,t_-e,r-FMTX of CCRF-CEM cell growth (Table 1) .
At 92-97% growth inhibition, effects of each compound could be reversed by the simultaneous presence of lo-' M leucovorin (not shown). In addition, in one experiment, CCRF-CEM sublines resistant to MTX because of reduced transport or increased DHFR were cross-resistant to D-MTX and n-e,t-FMTX. These results indicate that each drug was acting as an antifolate. Similar protection and cross-resistance experiments were not reported previously with D-MTX 121.
Data presented here indicate that MTX analogs containing D-Glu or o-eryfhro,threo-4-fluoroGlu exert growth inhibitory effects by mechanisms similar to MTX, but are markedly less potent. Decreased potency of both n-species appears to be a result of decreased uptake and weaker DHFR inhibition. Inability of n-enantiomercontaining analogs to form polyglutamate derivatives [18] probably contributed little to decreased potency here since polyglutamylation -_ is not essential under continuous exposure conditions 131. Previouslv 121. onlv weaker DHFR inhibition was recognized as a &t& in the decreased potency of D-MTX. The present results thus provide further evidence that D-MTX occurring (2) as a contaminant in MTX should not be of major concern in its clinical use. These results also validate the use of MTX analogs containing o,L-amino acids, Specifically, the results validate our earlier assumption that D-e,f-FMTX is essentially inactive compared to L-e,l-FMTX in the biological systems employed. Further. the results demonstrate that 4-fluorosubstitution in Glu does not alter stereospecificity in the folate-dependent systems examined.
These results are also of significance in terms of the future use of D,L-e,l-FMTX in vioo. Plasma clearance of D-MTX is as rapid as that of L-MTX [2] ; thus, if D,L-MTX was used, plasma ratios of D-b&f?kL-m should not rise to a value where the D-isomer could interfere with the action of L-MTX. This observation and the similarity in properties of m and FMTX suggest that D-e,r-FMTX and L-e.f-FMTX should be cleared with similar kinetics. Thii, c&pled with the low potency of the D-isomers, indicates that use of mixed isomers D,L-e,f-FMTX in uiuo should not have significant therapeutic disadvantages.
Insumma~,an~~gsofM~(4~amino-lO-methy1~teroyl-L-Glu) containing D-Glu (D-MTX) or D~~f~ro,f~~eo-4-fluoroGlu (o-e,t-FMTX) were characterized. D-MTX and D-e,t-FMTX were >98 and >96% enantiomerically pure, resoectivelv. bv enzvmatic assay. D-MTX and D-e,t-FMTX we;e less &teht inhibitors of *DHFR, [3H]MTX uptake, and folate-mediated dTMP biosynthesis than the Lenantiomer-~ntai~ng species. These properties were reflected in their decreased cytoxicity for CCRF-CEM cells compared to the L-enantio~er-containing species. These results indicate that MTX analoescontaining D-enantiomers of Glu or Glu analogs are less active than the L-enantiomercontaining counterparts at each key step in the mechanism of MTX and these decreased activities combine to produce lower overall biological activity.
